Revenue, 2023 (US$M)
$26.5
Forecast, 2030 (US$M)
$154.7
CAGR, 2024 - 2030
28.7%
Report Coverage
Canada

Canada bispecific antibodies market highlights

  • The Canada bispecific antibodies market generated a revenue of USD 26.5 million in 2023 and is expected to reach USD 154.7 million by 2030.
  • The Canada market is expected to grow at a CAGR of 28.7% from 2024 to 2030.
  • In terms of segment, cancer was the largest revenue generating type in 2023.
  • Cancer is the most lucrative type segment registering the fastest growth during the forecast period.

Bispecific antibodies market data book summary

Market revenue in 2023USD 26.5 million
Market revenue in 2030USD 154.7 million
Growth rate28.7% (CAGR from 2023 to 2030)
Largest segmentCancer
Fastest growing segmentCancer
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCancer
Key market players worldwideAmgen Inc, Roche Holding AG, Genentech, Akeso Inc Ordinary Shares, Janssen Pharmaceuticals, Taisho Pharmaceutical Holdings Co Ltd ADR, Immunocore Holdings PLC ADR

Other key industry trends

  • In terms of revenue, Canada accounted for 0.3% of the global bispecific antibodies market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. bispecific antibodies market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 94,021.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Bispecific Antibodies Market Scope

Bispecific antibodies market segmentation & scope

Bispecific Antibodies Market Companies

Name Profile # Employees HQ Website

Canada bispecific antibodies market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bispecific antibodies market will help companies and investors design strategic landscapes.


Cancer was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Canada bispecific antibodies market based on cancer covering the revenue growth of each sub-segment from 2018 to 2030.


  • Canada Bispecific Antibodies Type Outlook (Revenue, USD million, 2018-2030)
    • Inflammatory & Autoimmune Disorders
    • Cancer
    • Others

Reasons to subscribe to Canada bispecific antibodies market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Canada bispecific antibodies market databook

  • Our clientele includes a mix of bispecific antibodies market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Canada bispecific antibodies market , including forecasts for subscribers. This country databook contains high-level insights into Canada bispecific antibodies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Canada bispecific antibodies market size, by type, 2018-2030 (US$M)

Canada Bispecific Antibodies Market Outlook Share, 2023 & 2030 (US$M)

Canada bispecific antibodies market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more